Context Therapeutics Inc. (CNTX)

CIK 1842952 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Context Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001687078-26-000020
Aug 12, 2026SCHEDULE 13G/A0001140361-26-032506
Aug 5, 20268-K0001628280-26-053378
Aug 5, 202610-Q0001628280-26-053347
Jul 31, 2026SCHEDULE 13G/A0001214659-26-009404
Jul 31, 20268-K0001628280-26-051399
Jul 27, 2026SCHEDULE 13G0002012383-26-002242
Jun 26, 202640001628280-26-045784
Jun 26, 202640001628280-26-045762
Jun 26, 202640001628280-26-045775
Jun 26, 202640001628280-26-045780
Jun 26, 20268-K0001628280-26-045744
Jun 26, 202640001628280-26-045778
Jun 26, 202640001628280-26-045789
Jun 15, 20268-K0001628280-26-043042
May 18, 20268-K0001628280-26-035793
May 15, 2026SCHEDULE 13G/A0001172661-26-002036
May 14, 2026SCHEDULE 13G/A0001140361-26-021316
May 14, 2026SCHEDULE 13G0001214659-26-006201
May 12, 2026SCHEDULE 13G/A0000919574-26-002869
May 8, 2026SCHEDULE 13G/A0001213900-26-053988
May 6, 202610-Q0001628280-26-031267
May 1, 20268-K0001628280-26-029323
Apr 28, 2026DEFA14A0001628280-26-027942
Apr 28, 2026DEF 14A0001628280-26-027928